The prognostic risk score model was found to identify patients with gastric cancer who are suitable for anti-CTLA4 antibody immunotherapy sucessfully, and thereby also indicated that fatty acid metabolism is crucial for shaping individual TME characteristics. The gene discussed is CTLA4; the disease is gastric cancer.